Zhongshan Hongling Biotechnology Co., Ltd. was invested by a well-known large domestic pharmaceutical production group and was established in December 2018 in the Torch Development Zone of Zhongshan, Guangdong Province. The company's main research areas are polymer medical new materials and biomedical regenerative materials.
Currently, the company's R&D team has mastered internationally leading technologies such as the synthesis of 'coral-shaped water-based medical pressure-sensitive adhesive,' medical silicone gel formulation technology, and various medical tape coating techniques.
The company primarily provides medical auxiliary materials and new medical materials to large, well-known pharmaceutical companies, and supplies silicone gel auxiliary products to the medical aesthetic industry.
The actual patch test shows a super lo
D-level production workshop and labora
PhDs and expert team from the US
Obtained 20 patents
Hongling Product Test Report
The Hongling medical tape products have been tested by the third-party organization SGS and meet the international pressure-sensitive adhesive industry’s biocompatibility requirements for medical adhesives. They are also certified under REACH and RoHS, and do not contain heavy metals or toxic harmful compounds.
微信